Valuation: Titan Pharmaceuticals

Market Cap 6.13M 5.59M 5.15M 4.68M 8.78M 568M 9.23M 62.64M 24.9M 310M 23.01M 22.52M 973M P/E 2023
-1.11x
P/E 2024 -0.62x
Enterprise Value 3.3M 3.01M 2.77M 2.52M 4.73M 306M 4.97M 33.72M 13.4M 167M 12.39M 12.13M 524M EV / Sales 2023
0.11x
EV / Sales 2024 -
Free-Float
-
Yield 2023 *
-
Yield 2024 -
1 day-7.39%
Current month-95.05%
Current year-95.05%
3 years 0
Extreme 0
14.8
5 years 0
Extreme 0
31.8
10 years 0
Extreme 0
17,280.02

Financials

2023 2024
Net sales 184K 168K 154K 140K 264K 17.04M 277K 1.88M 747K 9.31M 690K 676K 29.21M -
Net income -5.57M -5.07M -4.67M -4.25M -7.98M -516M -8.38M -56.88M -22.61M -282M -20.89M -20.45M -884M -4.71M -4.29M -3.95M -3.59M -6.74M -436M -7.08M -48.07M -19.1M -238M -17.66M -17.28M -747M
Net Debt -6.2M -5.64M -5.2M -4.73M -8.87M -574M -9.32M -63.28M -25.15M -313M -23.24M -22.75M -983M -2.83M -2.58M -2.38M -2.16M -4.05M -262M -4.26M -28.92M -11.49M -143M -10.62M -10.4M -449M
Projected Income Statement - Annual - Titan Pharmaceuticals
Logo Titan Pharmaceuticals
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.
Employees
-
Sector
-
Date Price Change
20/11/26 US$0.2280 -7.39%
19/11/26 US$0.2462 -5.60%
18/11/26 US$0.2608 -0.72%
17/11/26 US$0.2627 -8.56%
16/11/26 US$0.2873 -9.20%
  1. Stock Market
  2. Stocks
  3. TTNP Stock